Gene Query: BRPF3

Dataset Description Geneva Score
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 65.56
Lysine benzoylation is a novel histone mark 42.35
Lysine benzoylation is a novel histone mark [RNA-seq] 42.35
miR941 overexpression experiment 40.14
MeRIP-seq for heat shock in B-cell lymphoma cells 33.69
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 33.3
Human HAP1 cells before and after nutrient deprivation 31.21
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 31.21
Differetially expressed genes after hTR overexpression in U2OS cells 29.66
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 24.99
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 24.7
RNA-seq in transgenic cells 24.05
Tracing Enhancer Networks using Epigenetic Traits (TENET) 23.5
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 23.49
ETV7 and interferon response 23.49
Fbxo32 mediated gene expression program underlies EMT and metastasis 22.38
Inhibition of TNBC metastasis by Gpx1 22.31
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 20.36
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 19.0
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 18.94
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 18.67
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 18.65
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 18.61
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 18.61
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 18.17
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 17.85
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 17.5
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 17.18
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 17.01
Gene expression analysis of dengue-infected cells 16.9
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  16.69
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 16.65
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 16.65
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 16.55
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 15.95
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 15.95
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 15.53
RNA-sequencing of human liver tissue 15.2
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 15.15
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 15.15
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 15.11
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 15.01
RNA-seq analysis of uveal melanoma cells treated with FR900359 14.95
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 14.69
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 14.69
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 14.4
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 14.16
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 14.14
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 14.14
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 14.06
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 14.03
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 14.03
RNAseq Analysis in glioblastoma cells treated with Mepazine 13.85
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 13.38
Transcriptome sequencing of K-562 cells 12.97
Rorc disruption in human FG pancreatic cancer cells 12.69
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 12.53
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 12.5
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 12.37
METTL3 promotes translation in human cancer cells 12.33
Active translatome profiling with RiboLace in MCF7 cells 12.12
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 12.04
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 11.93
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 11.87
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 11.55
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 11.51
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.4
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.4
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 11.37
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 11.3
Survival of pancreatic cancer cells lacking KRAS function 11.28
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 11.17
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 11.07
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.0
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 10.95
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 10.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.88
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 10.79
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 10.79
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 10.78
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 10.75
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 10.71
Tpl-2 small molecule project 10.59
Tpl-2 and MEK small molecule inhibitors 10.59
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 10.55
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 10.55
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 10.5
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 10.5
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 10.45
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 10.34
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 10.33
The landscape of alternative splicing in aggressive prostate cancers 10.32
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 10.14
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 10.13
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.11
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.05
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 10.0
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 9.93
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 9.86
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 9.76
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 9.68
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 9.68
Gene expression in PANC1 cells treated with Rakicidin 9.46
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 9.37
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 9.34
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.26
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 9.26
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.24
IRF1 regulates IFN dependent and independent gene expression 9.23
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.16
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.16
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 9.15
RNA-seq analysis of BAP1-depleted uveal melanoma cells 9.15
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.11
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 9.11
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.01
CHCHD2 gene KO effect in iPSC drived motor neurons 8.86
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 8.84
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 8.84
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.83
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 8.78
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.58
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.54
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.54
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 8.5
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.5
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 8.49
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.48
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.43
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.43
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 8.43
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 8.39
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 8.38
Effect of Hotair overexpression in human breast cancer cell lines 8.35
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 8.34
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 8.34
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 8.32
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.2
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.2
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.11
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 8.11
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.01
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.01
NKX2.2 7.99
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 7.99
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.99
Generation of KRAS signatures using immortalized isogenic lung cells. 7.98
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 7.97
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 7.94
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 7.9
Mechanistic Model-Guided Study of Embryonic Morphogenesis 7.88
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 7.84
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 7.84
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 7.82
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 7.8
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 7.79
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 7.73
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 7.7
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 7.7
Identification of Sin3B regulated genes during quiescence 7.69
DIGIT regulates endoderm differentiation of human embryonic stem cells 7.67
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.64
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 7.64
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.62
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 7.52
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.52
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.51
FBXW7 modulates stress response by post-translational modification of HSF1 7.51
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.51
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.51
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.44
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.41
Patient-derived luminal breast cancer xenografts with progestins 7.41
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 7.4
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.36
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 7.35
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 7.33
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 7.29
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 7.27
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 7.27
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.13
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 7.12
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.12
T47D RNA-seq and ChrRNA-seq data 7.12
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 7.12
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 7.06
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 7.06
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.03
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 7.0
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.0
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 6.99
DART-seq: an antibody-free method for global m6A detection 6.96
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.93
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 6.92
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 6.89
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 6.89
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.89
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.87
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 6.87
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 6.87
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.83
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.83
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 6.82
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 6.82
Gene expression profiling of leukemia cells following asparagine depletion 6.79
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.78
Tracking of dCas9-methyltransferase footprints 6.77
Glioblastoma stem cells infected by ZIKA virus 6.74
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 6.74
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.73
Overexpression of NFIB and YBX1 in MCF-7 cells 6.73
The bromodomain protein BRD4 regulates splicing during heat shock 6.72
High-throughput sequencing of pluripotent cells 6.69
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 6.67
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 6.66
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 6.62
Altering cancer transcriptomes using epigenomic inhibitors 6.62
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 6.61
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 6.6
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 6.58
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 6.57
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 6.57
TGF-β regulation of miRNA expression in pancreatic cancer 6.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.55
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 6.53
RNA transcriptome analysis during HSV-1 infection 6.5
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.5
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.5
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 6.49
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.46
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.43
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.42
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.42
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 6.4
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 6.37
RNA-seq of naive and primed ES cells (NHSM) 6.36
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 6.34
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 6.34
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.34
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 6.31
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 6.31
Silencing p300 in MCF7 cells to study expression and alternative splicing 6.29
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.26
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.19
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 6.19
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 6.16
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.1
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 6.1
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 6.1
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 6.08
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 6.08
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.07
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 6.06
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.98
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.9
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.87
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.86
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.86
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.85
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.85
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.85
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.83
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 5.83
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 5.79
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 5.78
Functional role of SLIT2 and ROBO1 in trophoblasts 5.78
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 5.77
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 5.77
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.76
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.74
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.71
SUV420H2 knockdown in PANC-1 5.68
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.65
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 5.61
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 5.61
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.61
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.6
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 5.59
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.58
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.56
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 5.55
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 5.55
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 5.55
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.53
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 5.52
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 5.47
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 5.47
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.47
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.44
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.4
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 5.39
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.38
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.37
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.27
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 5.23
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 5.23
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.22
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 5.21
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 5.21
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.19
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.16
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 5.11
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 5.11
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.11
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.07
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.07
RNA-sequencing 5.05
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.98
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 4.95
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 4.92
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.87
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 4.87
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.87
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.82
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 4.81
RNA-seq differential expression studies: more sequence, or more replication? 4.75
Global analysis of alternative splicing regulated by RBM10 4.73
X-Ray induced DNA-Hydroxymethylation changes 4.71
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.69
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 4.69
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 4.68
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 4.68
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 4.66
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.65
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.64
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.62
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.58
AUF-1 affected genes in human skin cells 4.57
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.51
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.44
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.42
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.42
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 4.37
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.36
Gene expressions of H9s in different culture systems 4.35
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.35
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.31
Silencing SPIB in attached and floating state of H1703 lung cancer cells 4.31
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.27
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 4.25
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.24
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.24
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.24
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.2
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 4.18
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.12
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.1
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.07
MARCKS and lnc-MARCKS act as inflammation regulators 4.06
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.88
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.88
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 3.86
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  3.83
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 3.81
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 3.79
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 3.79
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.76
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.74
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.61
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.61
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.6
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.6
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.57
Disruption of GRIN2B impairs differentiation in human neurons 3.55
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 3.46
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.46
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.45
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.44
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.43
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.34
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 3.28
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 3.28
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 3.25
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.13
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.1
Ribosomal protein RPL26 is the principal target of UFMylation 3.08
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 3.06
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.0
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.98
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 2.96
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.89
HEK293 TFAM Knockout Expression Study 2.85
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 2.85
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.84
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.84
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.81
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.72
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.64
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.64
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.63
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.63
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.6
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.6
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.55
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 2.5
MicroRNA targetome analysis during HCMV infection 2.47
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.44
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 2.37
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 2.31
The pioneer factor CEBPA modulates vitamin D signaling 2.31
The transcriptome effect of overexpressing EZH2 in MCF7 2.23
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.22
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 2.2
Effect of drugs on transcriptomic profiles 2.16
Gene expression analysis of human hepatocellular cancers 2.09
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 2.06
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 2.06
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 2.05
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.04
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.93
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.89
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.8
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.79
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 1.73
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.72
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.68
Interaction between mitoNEET and NAF-1 in cancer cells 1.56
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.55
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.54
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.52
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.52
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.52
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.49
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.45
Noncoding regions are the main source of targetable tumor-specific antigens 1.34
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.34
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.34
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.33
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.33
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.32
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.31
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.31
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.28
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.26
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.26
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.26
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.2
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.19
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.19
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.18
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.17
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.12
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.1
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.06
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.06
Gene expression analysis upon mtDNA depletion 1.06
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.03
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.99
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.96
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.95
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.95
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.95
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.94
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.94
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.94
Ribosome profiling upon inhibition of eIF4A 0.92
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.9
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.9
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.88
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.83
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.77
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.77
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.77
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.76
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.76
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.73
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.72
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.72
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.72
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.71
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.7
Gene expression activation in CLL mediated by MSCs contact 0.69
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.62
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.57
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.52
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 0.49
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.37
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.37
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.36
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.32
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.3
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.29
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.26
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.24
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.22
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.17
Expression analysis of the TAF1 syndrome 0.17
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.16
The DPYSL2 gene connects mTOR and schizophrenia 0.13
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.12
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.11
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.1
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.1
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.09
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.05
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.02
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.02
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01
Impact on erythroid progenitor type on erythroid differntiation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation